Photocure ASA announced that positive data from a Danish population registry study featuring nearly 10,000 bladder cancer patients was presented at the Nordisk Urologisk Forening (NUF) congress in Helsinki, Finland last week. NUF was being held June 8-11, 2022 as an in-person event for the first time since 2019. Photocure's presence at and commitment to NUF was reinforced by sponsoring the Residents Day event for this year's congress.

Nordic Residents in Urology is a NUF group, which aims to increase collaboration and networking between young urologists in the Nordic countries in order to improve overall education and research opportunities. Nordisk Urologisk Forening is an association of the national urological societies in Denmark, Norway, Sweden, Finland and Iceland, supporting close cooperation of Nordic urologists in various fields of education, science and clinical work. The NUF meeting is bi-annual, bringing together Nordic urologists, nurses and healthcare industry to meet and share best practice.

Photocure, The Bladder Cancer Company, was present in Helsinki during the whole event. In the scientific program on Bladder Cancer topics, BLC was prominently featured again this year: a Danish population study assessing recurrence and progression impact of BLC using national registries in Denmark was presented at NUF. The study abstract entitled “Use of photodynamic diagnosis (PDD) at primary TURB: Potential influence on recurrence and progression rates in NMIBC in a registry-based study using a country cohort” shows beneficial impact on recurrence and progression in patients treated at clinics who have a higher level of use of BLC in primary patients.

The results are based on data from nearly 10,000 patients identified through the Danish National Patient Registry, corresponding to all newly diagnosed NMIBC patients in Denmark in the period 2011-2017.